Rankings
▼
Calendar
CGEN
Compugen Ltd.
$215M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$8M
Net Income
-$8M
EPS (Diluted)
$-0.09
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
$0
Free Cash Flow
$0
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$143M
Total Liabilities
$16M
Stockholders' Equity
$127M
Cash & Equivalents
$133M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$8M
-$7M
-23.4%
Net Income
-$8M
-$6M
-19.6%
← FY 2020
All Quarters
Q4 2020 →
CGEN Q3 2020 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena